Lesley Wise

689 total citations
12 papers, 480 citations indexed

About

Lesley Wise is a scholar working on Toxicology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lesley Wise has authored 12 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Toxicology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lesley Wise's work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Drug-Induced Adverse Reactions (2 papers). Lesley Wise is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Drug-Induced Adverse Reactions (2 papers). Lesley Wise collaborates with scholars based in United Kingdom, United States and Netherlands. Lesley Wise's co-authors include Joanna Watson, Gabriela Czanner, Gillian Reeves, Jane Green, J. Green, V. Beral, June Raine, John A. Parkinson, Alasdair Breckenridge and Valerie Beral and has published in prestigious journals such as Nature Reviews Drug Discovery, International Journal of Cancer and European Respiratory Journal.

In The Last Decade

Lesley Wise

12 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Wise United Kingdom 9 219 156 71 69 60 12 480
Weng-Foung Huang Taiwan 16 104 0.5× 80 0.5× 92 1.3× 9 0.1× 82 1.4× 27 568
Greg Carney Canada 12 75 0.3× 57 0.4× 45 0.6× 12 0.2× 118 2.0× 37 620
Jetty A. Overbeek Netherlands 14 112 0.5× 54 0.3× 115 1.6× 8 0.1× 138 2.3× 57 716
Melina L Willson Australia 12 414 1.9× 51 0.3× 68 1.0× 6 0.1× 147 2.5× 21 732
Allison J Hahr United States 10 85 0.4× 131 0.8× 126 1.8× 10 0.1× 62 1.0× 14 417
Ansgar Hebborn Switzerland 8 233 1.1× 250 1.6× 66 0.9× 4 0.1× 46 0.8× 12 481
Jianhong Zhu China 10 136 0.6× 33 0.2× 85 1.2× 22 0.3× 85 1.4× 43 546
Sheryl L. Silfen United States 14 318 1.5× 157 1.0× 222 3.1× 8 0.1× 139 2.3× 25 994
Mayako Uchida Japan 14 218 1.0× 19 0.1× 95 1.3× 51 0.7× 45 0.8× 94 508
Timothy Goggin Switzerland 13 238 1.1× 40 0.3× 54 0.8× 3 0.0× 108 1.8× 22 690

Countries citing papers authored by Lesley Wise

Since Specialization
Citations

This map shows the geographic impact of Lesley Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Wise more than expected).

Fields of papers citing papers by Lesley Wise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Wise. The network helps show where Lesley Wise may publish in the future.

Co-authorship network of co-authors of Lesley Wise

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Wise. A scholar is included among the top collaborators of Lesley Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Wise. Lesley Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wing, Kevin, Elizabeth Williamson, James R. Carpenter, et al.. (2021). Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Health Technology Assessment. 25(51). 1–70. 4 indexed citations
2.
Wing, Kevin, Elizabeth Williamson, James R. Carpenter, et al.. (2020). Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials. European Respiratory Journal. 57(3). 2001586–2001586. 8 indexed citations
3.
Wing, Kevin, Elizabeth Williamson, James R. Carpenter, et al.. (2018). Real-world effects of medications for chronic obstructive pulmonary disease: protocol for a UK population-based non-interventional cohort study with validation against randomised trial results. BMJ Open. 8(3). e019475–e019475. 7 indexed citations
4.
Seabroke, Suzie, Lesley Wise, & Patrick Waller. (2013). Development of a Novel Regulatory Pharmacovigilance Prioritisation System: An Evaluation of Its Performance at the UK Medicines and Healthcare products Regulatory Agency. Drug Safety. 36(10). 1025–1032. 14 indexed citations
5.
Raine, June, Lesley Wise, Stuart Blackburn, H.-G. Eichler, & A Breckenridge. (2011). European Perspective on Risk Management and Drug Safety. Clinical Pharmacology & Therapeutics. 89(5). 650–654. 19 indexed citations
6.
Green, Jane, Gabriela Czanner, Gillian Reeves, et al.. (2011). Menopausal hormone therapy and risk of gastrointestinal cancer: Nested case–control study within a prospective cohort, and meta‐analysis. International Journal of Cancer. 130(10). 2387–2396. 72 indexed citations
7.
Wise, Lesley. (2011). Risks and benefits of (pharmaco)epidemiology. Therapeutic Advances in Drug Safety. 2(3). 95–102. 11 indexed citations
8.
Green, J., Gabriela Czanner, Gillian Reeves, et al.. (2010). Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ. 341(sep01 3). c4444–c4444. 195 indexed citations
9.
Wise, Lesley, John A. Parkinson, June Raine, & Alasdair Breckenridge. (2009). New approaches to drug safety: a pharmacovigilance tool kit. Nature Reviews Drug Discovery. 8(10). 779–782. 59 indexed citations
10.
Wise, Lesley, et al.. (2007). Signal Detection in the UK: The Use of Quantitative Methods at the MHRA. Drug Safety. 30(10). 919–990. 1 indexed citations
11.
Watson, Joanna, Lesley Wise, & Jane Green. (2007). Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. European Journal of Clinical Pharmacology. 63(9). 843–849. 74 indexed citations
12.
Waller, Patrick, et al.. (2005). Comparison of hospital episodes with ‘drug‐induced’ disorders and spontaneously reported adverse drug reactions. British Journal of Clinical Pharmacology. 61(2). 233–237. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weng-Foung Huang Breakdown of academic impact, for papers by Greg Carney Breakdown of academic impact, for papers by Jetty A. Overbeek Breakdown of academic impact, for papers by Melina L Willson Breakdown of academic impact, for papers by Allison J Hahr Breakdown of academic impact, for papers by Ansgar Hebborn Breakdown of academic impact, for papers by Jianhong Zhu Breakdown of academic impact, for papers by Sheryl L. Silfen Breakdown of academic impact, for papers by Mayako Uchida Breakdown of academic impact, for papers by Timothy Goggin
Rankless by CCL
2026